ANGELLE ADAMS: Open Payments
NPI 1487239018 · RACELAND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 15 payments from 7 companies in 2025. Trend: 2023 $212 · 2024 $215 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $35 |
| Corium, LLC | 2 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: ARISTADA, CAPLYTA, VRAYLAR, VIVITROL, AUSTEDO XR, Azstarys, SPRAVATO, UZEDY.
Industry payments across LA — which companies pay providers there.
